These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2458026

  • 21. Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
    Dorian P, Newman D, Berman N, Hardy J, Mitchell J.
    J Am Coll Cardiol; 1993 Jul; 22(1):106-13. PubMed ID: 8509529
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
    Nademanee K, Singh BN.
    Am J Cardiol; 1990 Jan 02; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality.
    Gill JS, Mehta D, Ward DE, Camm AJ.
    Br Heart J; 1992 Oct 02; 68(4):392-7. PubMed ID: 1449923
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI, Gilbert EM, Miller RH, Singh S, Freedman RA, Keefe DL, Saksena S, MacNeil DJ, Anderson JL.
    Am J Cardiol; 1991 Mar 01; 67(6):511-6. PubMed ID: 1705386
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J, Miura DS, Torres V, Flowers D, Keefe D, Williams S, Somberg JC.
    Am J Cardiol; 1985 Nov 15; 56(13):877-81. PubMed ID: 2414983
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL, Askins JC, Gilbert EM, Miller RH, Keefe DL, Somberg JC, Freedman RA, Haft LR, Mason JW, Lessem JN.
    J Am Coll Cardiol; 1986 Oct 15; 8(4):752-62. PubMed ID: 2428852
    [Abstract] [Full Text] [Related]

  • 36. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.
    Ho DS, Zecchin RP, Richards DA, Uther JB, Ross DL.
    Lancet; 1994 Jul 02; 344(8914):18-23. PubMed ID: 7912296
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
    Senges J, Lengfelder W, Jauernig R, Czygan E, Brachmann J, Rizos I, Cobbe S, Kübler W.
    Circulation; 1984 Mar 02; 69(3):577-84. PubMed ID: 6692518
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.